
    
      LEO 90105 ointment contains both calcipotriol and betamethasone dipropionate. It has been
      approved for the treatment of psoriasis in more than 60 centres, including most European
      countries, the US, China, Korea and Taiwan. This trial will investigate its safety and
      efficacy in the treatment of Japanese subjects with psoriasis.
    
  